Case of

HIV or HHV-8, which had demonstrated massive ascites, and discussed a possibility of an additional subcategory. Our case had mild pleural and pericardial effusion and slight ascites at onset. The role of HCV might not be limited to intraperitoneal B-cell clonal expansion.

[1]  J. Gisbert,et al.  Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. , 2003, Gastroenterology.

[2]  L. Prosnitz,et al.  Rituximab in lymphocyte predominance Hodgkin's disease: a case series. , 2003, Clinical lymphoma.

[3]  V. Devita.  Hodgkin's disease--clinical trials and travails. , 2003, The New England journal of medicine.

[4]  C. Herold,et al.  Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment , 2003, Leukemia.

[5]  Francisco Cervantes,et al.  Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. , 2003, The New England journal of medicine.

[6]  K. Krohn,et al.  Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority. , 2003, Blood.

[7]  R. Braziel,et al.  Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience. , 2002, Blood.

[8]  L. Kjeldsen,et al.  Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 , 2002, Leukemia.

[9]  S. Rudoy,et al.  Anti-CD20 Monoclonal Antibody Treatment of Human Herpesvirus 8-Associated, Body Cavity-Based Lymphoma with an Unusual Phenotype in a Human Immunodeficiency Virus-Negative Patient , 2001, Clinical Diagnostic Laboratory Immunology.

[10]  Meri,et al.  Rituximab (Anti‐CD20) Therapy of B‐Cell Lymphomas: Direct Complement Killing is Superior to Cellular Effector Mechanisms , 2000, Scandinavian journal of immunology.

[11]  H. Horiuchi,et al.  Steroid Hormone-responsive Secondary Factor X Deficiency , 1998, Thrombosis and Haemostasis.

[12]  A. Dachman,et al.  Primary non-Hodgkin's splenic lymphoma. , 1998, Clinical radiology.

[13]  M. Picardi,et al.  High prevalence of hepatitis C virus infection in patients with B‐cell lymphoproliferative disorders in Italy , 1997, American journal of hematology.

[14]  M. Varma,et al.  Normalization of plasma factor X levels in amyloidosis after plasma exchange , 1997, American journal of hematology.

[15]  E. Cesarman,et al.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. , 1996, Blood.

[16]  A. Andriulli,et al.  Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia. , 1996, Leukemia.

[17]  R. Chung,et al.  A role for hepatitis C virus infection in type II cryoglobulinemia. , 1992, The New England journal of medicine.

[18]  G. Berry,et al.  Primary non‐Hodgkin lymphoma of the spleen , 1991, American journal of hematology.

[19]  R. Weiss,et al.  Cytarabine and neurologic toxicity. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  P. Tabaczka,et al.  B lymphocytic lymphoma (large cell) of possible splenic marginal zone origin presenting with prominent splenomegaly and unusual cordal red pulp distribution , 1988, Cancer.

[21]  H. Lazarus,et al.  Cerebellar toxicity with high-dose cytosine arabinoside. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  P. Greipp,et al.  Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy. , 1987, The New England journal of medicine.

[23]  P. Greipp,et al.  Factor‐X deficiency in amyloidosis: A critical review , 1981, American journal of hematology.

[24]  R. Kyle,et al.  Factor X deficiency in primary amyloidosis: resolution after splenectomy. , 1979, The New England journal of medicine.

[25]  Pierre Morel,et al.  CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[26]  L. Cavanna,et al.  Primary lymphoma of the spleen. Report of a case with diagnosis by fine-needle guided biopsy. , 1995, Haematologica.